| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |